search
Back to results

Depression, Trauma, and Health: Efficacy of an mHealth App for Symptom Self-Management in College Students (DepTH)

Primary Purpose

Depression

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Happify Breather App
Sponsored by
Donna Schuman
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depression focused on measuring heart rate variability, autonomic function, biofeedback, mobile health

Eligibility Criteria

18 Years - 45 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 18-45;
  • University of Kentucky college student;
  • Self-reported low mood;
  • Own a smart phone or iPod (6th Generation or later).

Exclusion Criteria:

  • Score >/= 10 on the PHQ-9 measure from the PHQ-SADS;
  • Self-reported diagnosis of lung disease (e.g., Chronic Obstructive Pulmonary - Disease. Asthma requiring medication), coronary heart disease, stroke, or uncontrolled diabetes (HA1c>7.0);
  • Self-reported history or diagnosis of seizure disorder;
  • Self-reported prescription for tricyclic antidepressants and/or clozapine
  • Current smoking or vaping (use in last 30 days);
  • Previous participation in an HRV biofeedback study

Sites / Locations

  • Donna L. Schuman

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

For the intervention group, baseline measures on depression and heart rate variability will be obtained at baseline and post-test (21 days later). Intervention group subjects will use the Breather app twice daily, five minutes each time, for a period of 21 days.

For the control group, baseline measures on depression and heart rate variability will be obtained at baseline and post-test (21 days later).

Outcomes

Primary Outcome Measures

Depression
Change in scores on the Patient Health Questionnaire-9 (PHQ-9) from baseline to week 3
Low Frequency HRV
Change from baseline to week 3 measured by electrocardiogram
High Frequency HRV
Change from baseline to week 3 measured by electrocardiogram

Secondary Outcome Measures

Anxiety
Change from baseline to week 3 measured by scores on the GAD-7 (Generalized Anxiety Disorder-7)
Heart Rate Variability Low Frequency/High Frequency Ratio
Change from baseline to week 3 measured by electrocardiogram
Somatoform
Change from baseline to week 3 measured by scores on the PHQ-15 (Patient Health Questionnaire-15)
App Adherence
Number of times app is used over 21 days

Full Information

First Posted
September 16, 2019
Last Updated
January 3, 2022
Sponsor
Donna Schuman
Collaborators
Happify Inc., University of Kentucky
search

1. Study Identification

Unique Protocol Identification Number
NCT04094792
Brief Title
Depression, Trauma, and Health: Efficacy of an mHealth App for Symptom Self-Management in College Students
Acronym
DepTH
Official Title
Depression, Trauma, and Health (DepTH): Efficacy of an mHealth App for Symptom Self-Management in College Students
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Withdrawn
Why Stopped
PI moving to another university--study will not be done at UK; Coronavirus pandemic will likely delay start at University of Texas at Arlington
Study Start Date
November 5, 2019 (Anticipated)
Primary Completion Date
May 1, 2022 (Anticipated)
Study Completion Date
June 1, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Donna Schuman
Collaborators
Happify Inc., University of Kentucky

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study is designed to examine the efficacy of a mobile application heart rate variability biofeedback exercise on heart rate variability and depression. The main objective of this study is to assess the Breather app manufactured by Happify, Inc., as a tool for improving levels of depression and heart rate variability in college students.Happify™ Breather is a mobile app that provides users with HRV biofeedback aimed at improving mental health and wellness. Breather uses HRV sensors to help users control breathing, leading to calm and relaxation. The more relaxed users are, the more visually reinforcing scene elements will appear in the underwater environment of the game. Breather uses an optical sensor in a smartphone camera. During app use, users are cued by the app to breathe at 6 cycles/minute using a breath pacer. When the smartphone camera flash is illuminated, color signal changes are measured from the fingertip pressed to the camera lens. The study population is college students who score in the clinical range on the PHQ-9. Secondary outcomes include anxiety, somatoform symptoms, and app adherence.
Detailed Description
Although traditionally considered a healthy group, concern is mounting about the health and mental health of college students (Hunt & Eisenberg, 2010). Mental health problems, such as depression, often go untreated in young college-age adults (Saeb et al., 2015). Depression is associated with poor health outcomes (Rutter et al., 2013). Suicide, often associated with depression, is a leading cause of death in college students (Drapeau & McIntosh, 2015). Research suggests that stress-related interventions would be useful for college students at risk of poor mental health outcomes (Karatekin, 2017); however less is known about the impact of mobile health interventions on depression in college students. Studies have shown that heart rate variability (HRV), a potent all-cause morbidity and mortality indicator, is reduced in persons with depressive disorders (Kemp, Quintana, Felmingham, Matthews, & Jelinek, 2012). Although HRV is typically higher in college-age students because they are often younger, studies have shown that college students HRV biofeedback involves voluntary changes in breathing rate, rhythm, pattern, and quality. Within a few minutes of rhythmic stimulation of the cardiovascular system through slow paced breathing at around six breaths per minute, HRV biofeedback produces robust increases in HRV (Vaschillo, Vaschillo, & Lehrer, 2006). Emotional regulation, to include depressive symptoms, can be improved through HRV biofeedback (Henriques, Keffer, Abrahamson, & Horst, 2011; Siepmann, Aykac, Unterdörfer, Petrowski, & Mueck-Weymann, 2008). Smart phones offer an expedient way to deliver digital interventions that promote relaxation and improve mood. Happify™ Breather is a mobile app that provides users with HRV biofeedback aimed at improving mental health and wellness. Breather uses HRV sensors to help users control breathing, leading to calm and relaxation. The more relaxed users are, the more visually reinforcing scene elements will appear in the underwater environment of the game. Breather uses an optical sensor in a smartphone camera. During app use, users are cued by the app to breathe at 6 cycles/min using a breath pacer. When the smartphone camera flash is illuminated, red color signal changes (increasing with systole and decreasing with diastole) are measured from the fingertip pressed to the camera lens and sampled at 50 Hz. In a validation study, results obtained from the Happify™ HRV biofeedback Breather app were consistent with Holter monitor results (Stein, 2018). The app is free of charge and publicly available on the iTunes App Store. The primary objective of the study is to examine the efficacy of the Happify™ Breather app's biofeedback exercise in improving high frequency (HF) heart rate variability (HRV) measures and depression scores in students compared to control. Secondary outcomes are to test the efficacy of the app for anxiety and somatoform symptoms, as well as adherence to the app.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression
Keywords
heart rate variability, autonomic function, biofeedback, mobile health

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
two-group randomized controlled efficacy trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
For the intervention group, baseline measures on depression and heart rate variability will be obtained at baseline and post-test (21 days later). Intervention group subjects will use the Breather app twice daily, five minutes each time, for a period of 21 days.
Arm Title
Control
Arm Type
No Intervention
Arm Description
For the control group, baseline measures on depression and heart rate variability will be obtained at baseline and post-test (21 days later).
Intervention Type
Device
Intervention Name(s)
Happify Breather App
Intervention Description
Subjects in the intervention group will be cued to breathe at 6 breaths per minute and will receive real time heart rate variability biofeedback. As they increase HRV, screen elements will become more visually appealing.
Primary Outcome Measure Information:
Title
Depression
Description
Change in scores on the Patient Health Questionnaire-9 (PHQ-9) from baseline to week 3
Time Frame
3 weeks
Title
Low Frequency HRV
Description
Change from baseline to week 3 measured by electrocardiogram
Time Frame
3 weeks
Title
High Frequency HRV
Description
Change from baseline to week 3 measured by electrocardiogram
Time Frame
3 weeks
Secondary Outcome Measure Information:
Title
Anxiety
Description
Change from baseline to week 3 measured by scores on the GAD-7 (Generalized Anxiety Disorder-7)
Time Frame
3 weeks
Title
Heart Rate Variability Low Frequency/High Frequency Ratio
Description
Change from baseline to week 3 measured by electrocardiogram
Time Frame
3 weeks
Title
Somatoform
Description
Change from baseline to week 3 measured by scores on the PHQ-15 (Patient Health Questionnaire-15)
Time Frame
3 weeks
Title
App Adherence
Description
Number of times app is used over 21 days
Time Frame
3 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 18-45; University of Kentucky college student; Self-reported low mood; Own a smart phone or iPod (6th Generation or later). Exclusion Criteria: Score >/= 10 on the PHQ-9 measure from the PHQ-SADS; Self-reported diagnosis of lung disease (e.g., Chronic Obstructive Pulmonary - Disease. Asthma requiring medication), coronary heart disease, stroke, or uncontrolled diabetes (HA1c>7.0); Self-reported history or diagnosis of seizure disorder; Self-reported prescription for tricyclic antidepressants and/or clozapine Current smoking or vaping (use in last 30 days); Previous participation in an HRV biofeedback study
Facility Information:
Facility Name
Donna L. Schuman
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40506
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Depression, Trauma, and Health: Efficacy of an mHealth App for Symptom Self-Management in College Students

We'll reach out to this number within 24 hrs